These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38293112)

  • 21. Engineering Axl specific CAR and SynNotch receptor for cancer therapy.
    Cho JH; Okuma A; Al-Rubaye D; Intisar E; Junghans RP; Wong WW
    Sci Rep; 2018 Mar; 8(1):3846. PubMed ID: 29497107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of highly effective LCB1-based lipopeptides targeting the spike receptor-binding motif of SARS-CoV-2.
    Zhu Y; Li M; Liu N; Wu T; Han X; Zhao G; He Y
    Antiviral Res; 2023 Mar; 211():105541. PubMed ID: 36682464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
    Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance profile and mechanism of severe acute respiratory syndrome coronavirus-2 variants to LCB1 inhibitor targeting the spike receptor-binding motif.
    Wu T; Zhu Y; Liu N; Hu Y; Chong H; He Y
    Front Microbiol; 2022; 13():1022006. PubMed ID: 36304946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Off-the-shelf CAR natural killer cells secreting IL-15 target spike in treating COVID-19.
    Lu T; Ma R; Dong W; Teng KY; Kollath DS; Li Z; Yi J; Bustillos C; Ma S; Tian L; Mansour AG; Li Z; Settles EW; Zhang J; Keim PS; Barker BM; Caligiuri MA; Yu J
    Nat Commun; 2022 May; 13(1):2576. PubMed ID: 35546150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models.
    Hyrenius-Wittsten A; Su Y; Park M; Garcia JM; Alavi J; Perry N; Montgomery G; Liu B; Roybal KT
    Sci Transl Med; 2021 Apr; 13(591):. PubMed ID: 33910981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Programmable synthetic receptors: the next-generation of cell and gene therapies.
    Teng F; Cui T; Zhou L; Gao Q; Zhou Q; Li W
    Signal Transduct Target Ther; 2024 Jan; 9(1):7. PubMed ID: 38167329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.
    Liu L; Patel B; Ghanem MH; Bundoc V; Zheng Z; Morgan RA; Rosenberg SA; Dey B; Berger EA
    J Virol; 2015 Jul; 89(13):6685-94. PubMed ID: 25878112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A synthetic notch (synNotch) system linking intratumoral immune-cancer cell communication to a synthetic blood biomarker assay.
    Fu Y; Wang T; Ronald JA
    Front Pharmacol; 2023; 14():1304194. PubMed ID: 38143496
    [No Abstract]   [Full Text] [Related]  

  • 30. De novo-designed transmembrane domains tune engineered receptor functions.
    Elazar A; Chandler NJ; Davey AS; Weinstein JY; Nguyen JV; Trenker R; Cross RS; Jenkins MR; Call MJ; Call ME; Fleishman SJ
    Elife; 2022 May; 11():. PubMed ID: 35506657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and mathematical analysis of activating transcriptional amplifiers that enable modular temporal control in synthetic juxtacrine circuits.
    Lam C
    Synth Syst Biotechnol; 2023 Dec; 8(4):654-672. PubMed ID: 37868744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma.
    Shin J; Parker MFL; Zhu I; Alanizi A; Rodriguez CI; Liu R; Watchmaker PB; Kalita M; Blecha J; Luu J; Wright B; Lapi SE; Flavell RR; Okada H; Tlsty TD; Roybal KT; Wilson DM
    J Nucl Med; 2023 Jan; 64(1):137-144. PubMed ID: 35981900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo design of modular and tunable protein biosensors.
    Quijano-Rubio A; Yeh HW; Park J; Lee H; Langan RA; Boyken SE; Lajoie MJ; Cao L; Chow CM; Miranda MC; Wi J; Hong HJ; Stewart L; Oh BH; Baker D
    Nature; 2021 Mar; 591(7850):482-487. PubMed ID: 33503651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting.
    Ruffo E; Butchy AA; Tivon Y; So V; Kvorjak M; Parikh A; Adams EL; Miskov-Zivanov N; Finn OJ; Deiters A; Lohmueller J
    Nat Commun; 2023 May; 14(1):2463. PubMed ID: 37160880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific Activation of T Cells by an ACE2-Based CAR-Like Receptor upon Recognition of SARS-CoV-2 Spike Protein.
    Gonzalez-Garcia P; Muñoz-Miranda JP; Fernandez-Cisnal R; Olvera L; Moares N; Gabucio A; Fernandez-Ponce C; Garcia-Cozar F
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108807
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Quijano-Rubio A; Yeh HW; Park J; Lee H; Langan RA; Boyken SE; Lajoie MJ; Cao L; Chow CM; Miranda MC; Wi J; Hong HJ; Stewart L; Oh BH; Baker D
    bioRxiv; 2020 Jul; ():. PubMed ID: 32743576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans.
    Alsoussi WB; Malladi SK; Zhou JQ; Liu Z; Ying B; Kim W; Schmitz AJ; Lei T; Horvath SC; Sturtz AJ; McIntire KM; Evavold B; Han F; Scheaffer SM; Fox IF; Mirza SF; Parra-Rodriguez L; Nachbagauer R; Nestorova B; Chalkias S; Farnsworth CW; Klebert MK; Pusic I; Strnad BS; Middleton WD; Teefey SA; Whelan SPJ; Diamond MS; Paris R; O'Halloran JA; Presti RM; Turner JS; Ellebedy AH
    Nature; 2023 May; 617(7961):592-598. PubMed ID: 37011668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant.
    Gray LT; Raczy MM; Briquez PS; Marchell TM; Alpar AT; Wallace RP; Volpatti LR; Sasso MS; Cao S; Nguyen M; Mansurov A; Budina E; Watkins EA; Solanki A; Mitrousis N; Reda JW; Yu SS; Tremain AC; Wang R; Nicolaescu V; Furlong K; Dvorkin S; Manicassamy B; Randall G; Wilson DS; Kwissa M; Swartz MA; Hubbell JA
    Biomaterials; 2021 Nov; 278():121159. PubMed ID: 34634664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines
    Ma MT; Badeti S; Chen CH; Kim J; Choudhary A; Honnen B; Reichman C; Calianese D; Pinter A; Jiang Q; Shi L; Zhou R; Xu H; Li Q; Gause W; Liu D
    Front Immunol; 2021; 12():652223. PubMed ID: 34367128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.